POLARAMINE 2 mg TABLETS
How to use POLARAMINE 2 mg TABLETS
Translated with AI
This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.
Show originalContents of the leaflet
Introduction
Package Leaflet: Information for the User
Polaramine 2 mg Tablets
Dexclorfeniramine Maleate
Read this package leaflet carefully before you start taking this medicine because it contains important information for you.
- Keep this package leaflet, you may need to read it again.
- If you have any further questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
- If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.
Contents of the Package Leaflet
- What is Polaramine and what is it used for
- What you need to know before you take Polaramine
- How to take Polaramine
- Possible side effects
- Storage of Polaramine
- Contents of the pack and further information
1. What is Polaramine and what is it used for
Dexclorfeniramine belongs to a group of medicines known as antihistamines.
Polaramine is indicated for the symptomatic treatment of seasonal and perennial allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, uncomplicated mild allergic skin manifestations of urticaria and angioedema, and reactions to blood or plasma. It is also indicated in the treatment of anaphylactic reactions in conjunction with adrenaline or other appropriate measures, after controlling acute manifestations. Polaramine often relieves skin manifestations such as allergic eczema, atopic dermatitis, and contact dermatitis, insect bites, dermatographism, and drug reactions.
2. What you need to know before you take Polaramine
Do not take Polaramine
- Polaramine should not be administered to newborns and premature infants.
- If you are under treatment with a special type of antidepressants known as monoamine oxidase inhibitors (MAOIs) or during the two weeks following the interruption of treatment.
Warnings and Precautions
Consult your doctor or pharmacist before starting to take Polaramine:
Children
The safety and efficacy of Polaramine in children under 6 years of age have not been established, so it should not be administered to these patients. Polaramine may cause nervousness and restlessness, especially in children.
Taking Polaramine with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
A special type of antidepressants known as monoamine oxidase inhibitors (MAOIs) prolong and intensify the effect of antihistamines, which may cause severe hypotension, i.e., severe drops in blood pressure.
The simultaneous use of Polaramine with tricyclic antidepressants, barbiturates, or other medicines that act on the central nervous system may potentiate the sedative effect of Polaramine.
Medicines of the Polaramine group (antihistamines) may decrease the action of oral anticoagulants, so you should consult your doctor before taking Polaramine.
Taking Polaramine with food, drinks, and alcohol
The simultaneous use of Polaramine with alcohol may potentiate the sedative effect of Polaramine.
Interaction with laboratory tests
Treatment with Polaramine should be suspended at least 48 hours before performing any skin allergy test, as medicines of the Polaramine group (antihistamines) may mask the result of these tests.
Pregnancy, Breast-feeding, and Fertility
If you are pregnant or breast-feeding, think you may be pregnant, or are planning to have a baby, ask your doctor for advice before taking this medicine.
Pregnancy
Polaramine should not be administered during the third trimester of pregnancy because newborns and premature infants may have severe reactions to antihistamines.
During the first two trimesters of pregnancy, Polaramine should only be used if your doctor considers it necessary.
Breast-feeding
It is unknown whether Polaramine is excreted in human milk, so you should consult your doctor if you are breast-feeding.
Driving and using machines
Polaramine may cause somnolence, altering mental and/or physical ability. If you notice these effects, avoid driving vehicles or using machines.
Polaramine contains lactose
This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
3. How to take Polaramine
Follow exactly the administration instructions of this medicine indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Your doctor will indicate your individualized dose according to the needs of the disease and your response.
In adults and children from 12 years: the recommended dose is one tablet 3 or 4 times a day, up to a maximum of 6 tablets a day.
Use in children
Children from 6 to 12 years: a maximum total of 3 tablets divided into three doses.
Swallow the tablets with a sufficient amount of liquid - a glass of water.
If you take more Polaramine than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, telephone (91) 562 04 20, indicating the medicine and the amount ingested.
If you forget to take Polaramine
Do not take a double dose to make up for forgotten doses.
If you have any other questions on the use of this medicine, ask your doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The most frequently observed side effect with the use of Polaramine (antihistamines) is mild to moderate somnolence. General side effects such as urticaria, skin rash, severe allergic reactions (anaphylactic shock), sensitivity to light, excessive sweating, chills, dryness of mouth, nose, and throat have been reported.
Other side effects that may occur with the use of antihistamines are the following: cardiovascular reactions, blood reactions, nervous system reactions, gastrointestinal reactions, genitourinary reactions, and respiratory reactions.
Reporting of side effects:
If you experience any side effects, talk to your doctor or pharmacist, even if it is possible side effects not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
5. Storage of Polaramine
Keep this medicine out of the sight and reach of children.
This medicine does not require any special storage conditions.
Do not use this medicine after the expiry date which is stated on the packaging after EXP. The expiry date is the last day of the month indicated.
Medicines should not be disposed of via wastewater or household waste. Place the packaging and any unused medicine in the SIGRE collection point at your pharmacy. If you have any further questions on how to dispose of the packaging and any unused medicine, ask your pharmacist. This will help protect the environment.
6. Contents of the pack and further information
Composition of Polaramine
- The active substance is dexclorfeniramine maleate. Each Polaramine tablet contains 2 mg of dexclorfeniramine maleate.
- The other ingredients are lactose, pregelatinized starch (from corn), corn starch, magnesium stearate, and purified water.
Appearance of the product and contents of the pack
White, round, flat tablets with beveled edges and scored on one face.
Each pack contains 20 tablets.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder |
Laboratorios Farmacéuticos ROVI, S.A. Julián Camarillo, 35 28037 Madrid Spain |
Manufacturer
ROVI Pharma Industrial Services, S.A.
Vía Complutense, 140,
Alcalá de Henares, 28805
Madrid
Spain
Date of last revision of this leaflet: March 2007
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
- Country of registration
- Average pharmacy price3.34 EUR
- Active substance
- Prescription requiredYes
- Manufacturer
- This information is for reference only and does not constitute medical advice. Always consult a doctor before taking any medication. Oladoctor is not responsible for medical decisions based on this content.
- Alternatives to POLARAMINE 2 mg TABLETSDosage form: INJECTABLE, 5mg/mlActive substance: dexchlorpheniramineManufacturer: Accord Healthcare S.L.U.Prescription requiredDosage form: ORAL SOLUTION/SUSPENSION, 0.4 mg/mlActive substance: dexchlorpheniramineManufacturer: Laboratorios Farmaceuticos Rovi S.A.Prescription requiredDosage form: INJECTABLE, 5 mg/1 mlActive substance: dexchlorpheniramineManufacturer: Laboratorios Farmaceuticos Rovi S.A.Prescription required
Online doctors for POLARAMINE 2 mg TABLETS
Discuss questions about POLARAMINE 2 mg TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.
Frequently Asked Questions